养正消积胶囊, Yangzheng Xiaoji Capsule, 36 Capsules

Medicine Name
Yangzheng Xiaoji Capsule
Yangzheng Xiaoji Jiaonang

Ingredients
Astragalus, Fructus Ligustri Lucidi, Ginseng, Curcuma Zedoaria, Ganoderma Lucidum, Gynostemma Pentaphyllum, Atractylodes Macrocephala (Fried), Scutellaria Barbata, Oldenlandia Diffusa, Poria Cocos, Steleophaga Plancyi, Chicken Gizzard and Endothelium, Indian Mockberry, Solanum Dulcamara, Wormwood (Artemisia Capillaris), Cynanchum Paniculatum

Properties
This product is a hard capsule with brown powder inside; it has a fragrant odor and a bitter, astringent taste.

Functions and Indications
It strengthens the spleen and kidneys, resolves blood stasis, and detoxifies. It is suitable for adjuvant therapy in cases of primary liver cancer with spleen and kidney deficiency and internal blockage of blood stasis and toxin, particularly in those not suitable for surgery. When used in combination with intra-arterial infusion and embolization chemotherapy for liver cancer, it helps to enhance the efficacy of interventional chemotherapy, reduce its toxic effects on white blood cells, liver function, and hemoglobin, improve patients' quality of life, alleviate abdominal distension, poor appetite, fatigue, weakness of the waist and knees, dark urine and loose stools, and pain.

Specifications
Each capsule contains 0.39g.

Dosage and Administration
Oral. Take 4 capsules each time, 3 times a day.

Adverse Reactions
Post-marketing surveillance data indicates that allergic reactions such as rash and pruritus may occur with this product.

Contraindications
Those allergic to any component of this product should avoid using it.

Precautions
After opening the moisture-proof bag, ensure the product remains dry.

Pharmacology and Toxicology
Major pharmacodynamics tests have shown that this product inhibits transplanted tumors S180, solid tumors of liver cancer HAC, and Lewis lung cancer in mice; it also inhibits human liver cancer SMMC7721 transplanted in nude mice. When used in combination with low-dose chemotherapy drugs, it demonstrates a certain synergistic effect in inhibiting the growth of sarcoma S180 in mice. It promotes the proliferation of splenic lymphocytes, NK cell activity, and IL-2 production in tumor-bearing mice. Additionally, it has a certain elevating effect on white blood cell counts reduced by cyclophosphamide in mice.

Storage
Seal tightly.

Packaging
Aluminum-plastic board packaging. 3 boards of 12 capsules per board per box.

Expiration
30 months.